These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22214461)

  • 21. Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.
    Shanmugam MK; Warrier S; Kumar AP; Sethi G; Arfuso F
    Curr Vasc Pharmacol; 2017; 15(6):503-519. PubMed ID: 28707601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promising early results for immunotherapy-antiangiogenesis combination.
    Garber K
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25421345
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of IL-12 in Cancer.
    Lu X
    Curr Cancer Drug Targets; 2017; 17(8):682-697. PubMed ID: 28460617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginseng on Cancer: Potential Role in Modulating Inflammation-Mediated Angiogenesis.
    Dai D; Zhang CF; Williams S; Yuan CS; Wang CZ
    Am J Chin Med; 2017; 45(1):13-22. PubMed ID: 28068835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalidomide: mechanisms of action.
    Paravar T; Lee DJ
    Int Rev Immunol; 2008; 27(3):111-35. PubMed ID: 18437602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostanoids as regulators of innate and adaptive immunity.
    Hirata T; Narumiya S
    Adv Immunol; 2012; 116():143-74. PubMed ID: 23063076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate effector cells in angiogenesis and lymphangiogenesis.
    Varricchi G; Loffredo S; Galdiero MR; Marone G; Cristinziano L; Granata F; Marone G
    Curr Opin Immunol; 2018 Aug; 53():152-160. PubMed ID: 29778674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic application of anti-angiogenic nanomaterials in cancers.
    Mukherjee S; Patra CR
    Nanoscale; 2016 Jul; 8(25):12444-70. PubMed ID: 27067119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment.
    Yi M; Jiao D; Qin S; Chu Q; Wu K; Li A
    Mol Cancer; 2019 Mar; 18(1):60. PubMed ID: 30925919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research progress on the mechanism of pro-inflammatory regression mediators promoting inflammation regression by regulating immune cells].
    Wang J; Xia H; Yao S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jul; 32(7):873-876. PubMed ID: 32788028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cells that mediate innate immune memory and their functional significance in inflammatory and infectious diseases.
    Gardiner CM; Mills KH
    Semin Immunol; 2016 Aug; 28(4):343-50. PubMed ID: 26979658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immune cells for immunotherapy of autoimmune and cancer disorders.
    Schäfer C; Ascui G; Ribeiro CH; López M; Prados-Rosales R; González PA; Bueno SM; Riedel CA; Baena A; Kalergis AM; Carreño LJ
    Int Rev Immunol; 2017 Nov; 36(6):315-337. PubMed ID: 28933579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
    Sato Y
    Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
    Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles for Innate Immunity in Combination Immunotherapies.
    Moynihan KD; Irvine DJ
    Cancer Res; 2017 Oct; 77(19):5215-5221. PubMed ID: 28928130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fresh Evidence for Platelets as Neuronal and Innate Immune Cells: Their Role in the Activation, Differentiation, and Deactivation of Th1, Th17, and Tregs during Tissue Inflammation.
    Ponomarev ED
    Front Immunol; 2018; 9():406. PubMed ID: 29599771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-12: biological properties and clinical application.
    Del Vecchio M; Bajetta E; Canova S; Lotze MT; Wesa A; Parmiani G; Anichini A
    Clin Cancer Res; 2007 Aug; 13(16):4677-85. PubMed ID: 17699845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
    Folkman J
    Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.